FDF brings every aspect of the finished dosage supply chain together in one location, from Big Pharma and CMO, to out-licensing specialists, end product distributors, end-user agents and home markets.
"Demand for generic medicines continues to grow, driven by mounting patent losses, efforts to cut healthcare spending and the increased incidence of age and life-style related diseases"
165+ countries represented
19% of visitors interested in Finished Formulations
47% are C-Suite Executives